FcRn-/- hFcRn (line 276) Tg mice are useful in evaluating the pharmacokinetics and pharmacodynamics of human immunoglobulin G (hIgG), such as therapeutic IgG. These mice carry a null mutation for the mouse gene and a transgene expressing the human FcRn α-chain under the control of the ubiquitous CAG promoter.
Need assistance evaluating antibodies in FcRn mice? Human preclinical pharmacokinetic (PK) analysis is available. See our FcRn full service platform.
Dr. Derry Roopenian, The Jackson Laboratory
|Transgenic (Inserted expressed sequence, Humanized sequence)|
|Allele Type||Gene Symbol||Gene Name|
|Targeted (Null/Knockout)||Fcgrt||Fc receptor, IgG, alpha chain transporter|
FcRn-/- hFcRn (276) Tg mice harbor a knockout allele of the FcRn α-chain (Fcgrttm1Dcr) and express the human FcRn α-chain cDNA (FCGRT) under the control the human cytomegalovirus immediate early promoter/enhancer with chicken beta-actin/rabbit beta-globin hybrid promoter (CAG). FcRn-/- mice (see Stock No. 003982) lack murine FcRn α-chain expression and fail to transport IgG across the neonatal gut; they do not recycle IgG and albumin and therefore show low plasma levels of both. In FcRn-/- hFcRn (276) Tg mice, plasma albumin levels are similar to wild-type mice, however the serum IgG levels remain low due to the species-specific behavior of human FcRn. A number of studies have shown this model's usefulness for pharmacokinetic and pharmacodynamic studies of human IgG and to screen hIgGs, with regard to their serum half-life. For example, human antibodies engineered to have enhanced binding to human FcRn (Hu4D5-IgG1, directed against human EGFR2) exhibit a significant increase in their serum half-life (2-2.5 fold) in these mice. Specifically, longer half-lives are observed in this strain with mice homozygous for the hFcRn transgene (hFcRn Tg/Tg) when compared to mice hemizygous for the hFcRn transgene (hFcRn Tg/0), indicating that higher copy number correlates with higher expression of FCGRT and provides greater protection of IgG from clearance. This mouse model is useful for studying human FcRn biology and the behavior of IgG antibodies and Fc-domain proteins, including Fc-engineered molecules.
FcRn α-chain knockout mice expressing a human FcRn transgene (line 276) are also called FcRn-/- hFcRn (276) Tg mice, cDNA transgenic line 276, mFcRn-/- hFcRn (276) Tg [carrying one allele of the transgene], or mFcRn-/- hFcRn (276) Tg/Tg [carrying two alleles of the transgene]. These FcRn-/- hFcRn (276) Tg mice were generated in the laboratory of Derry Roopenian (The Jackson Laboratory) by crossing Fcgrttm1Dcr targeted mutant mice (backcrossed five generations to C57BL/6J) with Tg(CAG-FCGRT)276Dcr transgenic mice (coisogenic on a C57BL/6J genetic background). These double mutant mice were backcrossed for several additional generations to C57BL/6J (~N11) prior to transfer to The Jackson Laboratory Repository.
To generate the FcRn α-chain knockout mice (Fcgrttm1Dcr; see also Stock No. 003982), a targeting vector was designed to replace 1588 nucleotide fragments (encoding promoter sequence 5' of the transcriptional start site, exon1, intron 2, and most of exon2) with a PGK-Neor cassette. The vector was electroporated into 129X1/SvJ-derived ESV/J-1182 embryonic stem (ES) cells. Correctly targeted ES cells were injected into recipient blastocysts. The resulting chimeric animals were crossed to C57BL/6J mice. These FcRn α-chain mutant mice were backcrossed to C57BL/6J for five generations prior to breeding with hFcRn line 276 transgenic mice.
To generate the hFcRn line 276 transgenic mice, a transgene was designed with the 0.34 kb human cytomegalovirus immediate early promoter enhancer, 1.4 kb chicken beta-actin promoter and intron 1, a cDNA sequence encoding the human FcRn α-chain, 0.73 kb rabbit beta-globin intron, and 0.35 kb SV40 polyA sequence. The donating investigator reports that this transgene was injected into C57BL/6J embryos. The resulting transgenic offspring were bred to C57BL/6J mice to establish founder line 276. These hFcRn line 276 transgenic mice were maintained on a C57BL/6J genetic background.
|Expressed Gene||FCGRT, Fc fragment of IgG receptor and transporter, human|
|Site of Expression|
|Site of Expression|
|Allele Name||transgene insertion 276, Derry C Roopenian|
|Allele Type||Transgenic (Inserted expressed sequence, Humanized sequence)|
|Allele Synonym(s)||Tg(CAG-FCGRT)276Dcr; transgene insertion 276, Derry C Roopenian|
|Gene Symbol and Name||Tg(CAG-FCGRT)276Dcr, transgene insertion 276, Derry C Roopenian|
|Gene Synonym(s)||hFcRn (276) Tg|
|Promoter||ACTB, actin, beta, chicken|
|Expressed Gene||FCGRT, Fc fragment of IgG receptor and transporter, human|
|Strain of Origin||C57BL/6J|
|Molecular Note||To generate the hFcRn line 276 transgenic mice, a transgene was designed with the 0.34 kb human cytomegalovirus immediate early promoter enhancer, 1.4 kb chicken beta-actin promoter and intron 1, a cDNA sequence encoding the human FcRn alpha-chain, 0.73 kb rabbit beta-globin intron, and 0.35 kb SV40 polyA sequence. Line 276 was established. Transgene insertion occurred on Chr 1, causing a 1 bp duplication.|
|Allele Name||targeted mutation 1, Derry C Roopenian|
|Allele Type||Targeted (Null/Knockout)|
|Allele Synonym(s)||targeted mutation 1, Derry C Roopenian; Fcgrttm1Dcr|
|Gene Symbol and Name||Fcgrt, Fc receptor, IgG, alpha chain transporter|
|Gene Synonym(s)||alpha-chain; FCRN; neonatal Fc receptor; FcRn|
|Strain of Origin||129X1/SvJ|
|Molecular Note||Sequence from exon 1 and part of exon2 was replaced with a PGK-neo cassette. Quantitative PCR of liver cDNA indicated the absence of mRNA. Western blot analysis of neonatal intestinal extracts failed to reveal protein product.|
When using the FcRn KO hFcRn Tg mouse strain in a publication, please cite the originating article(s) and include JAX stock #004919 in your Materials and Methods section.
|Heterozygous for Fcgrt<tm1Dcr>, Hemizygous for Tg(CAG-FCGRT)276Dcr|
We will fulfill your order by providing at least two carriers for each strain ordered. The total number, sex, and genotypes provided will vary, although typically 8 or more animals are provided. Please check genotypes which will be recovered. While the genotypes of all animals produced will be communicated to you prior to scheduling shipment, the genotypes of animals provided may not reflect the mating scheme and genotypes described in the strain description. Animals are typically ready to ship in 11-14 weeks. If a second recovery is required to produce the minimum number of animals, then delivery time would increase to approximately 25 weeks. If we fail to produce animals of the correct genotype, you will not be charged. We cannot guarantee the reproductive success of mice shipped to your facility. If the mice are lost after the first three days (post-arrival) or do not produce progeny at your facility, a new order and fee will be necessary.
Cryorecovery to establish a Dedicated Supply for greater quantities of mice. Mice recovered can be used to establish a dedicated colony to contractually supply you mice according to your requirements. Price by quotation.
|Frozen Mouse Embryo||$2,595.00 per straw or vial|
"MICE" means mouse strains, their progeny derived by inbreeding or crossbreeding, unmodified derivatives from mouse strains or their progeny supplied by The Jackson Laboratory ("JACKSON"). "PRODUCT(S)" means biological materials supplied by JACKSON, and their derivatives. "SERVICES" means projects conducted by JACKSON for other parties that may include but are not limited to the use of MICE or PRODUCTS. "RECIPIENT" means each recipient of MICE, PRODUCTS, or SERVICES provided by JACKSON including each institution, its employees and other researchers under its control. MICE or PRODUCTS shall not be: (i) used for any purpose other than internal research, (ii) sold or otherwise provided to any third party for any use, or (iii) provided to any agent or other third party to provide breeding or other services. Acceptance of MICE, PRODUCTS or SERVICES from JACKSON shall be deemed as agreement by RECIPIENT to these conditions, and departure from these conditions requires JACKSON’s prior written authorization.
MICE, PRODUCTS AND SERVICES ARE PROVIDED "AS IS". JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of, PRODUCTS or SERVICES, JACKSON will, at its option, provide credit or replacement for the PRODUCT received or the SERVICES provided; JACKSON makes no other representations and this shall be the exclusive remedy of the purchaser. Please note specific policy for live mice.
Consistent with the requirement for a written understanding regarding animal care and use, the JACKSON Animal Care and Use Committee will review the animal care and use protocol(s) associated with any SERVICES to be performed at JACKSON, and JACKSON shall have ultimate responsibility and authority for the care of animals while on site or in JACKSON custody.
In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS, or SERVICES, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. Unless prohibited by law, in purchasing or receiving MICE, PRODUCTS, or SERVICES from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.
MICE, PRODUCTS or SERVICES are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or SERVICES. In addition, special terms and conditions of sale of certain MICE, PRODUCTS, or SERVICES may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and SERVICES by JACKSON, and by its licensees and distributors.
Acceptance of delivery of MICE, PRODUCTS or SERVICES shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or SERVICES by JACKSON.